Sravan Kumar Emany - Net Worth and Insider Trading
Sravan Kumar Emany Net Worth
The estimated net worth of Sravan Kumar Emany is at least $1 Million dollars as of 2024-11-12. Sravan Kumar Emany is the SVP, CFO of Ironwood Pharmaceuticals Inc and owns about 301,733 shares of Ironwood Pharmaceuticals Inc (IRWD) stock worth over $1 Million. Details can be seen in Sravan Kumar Emany's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sravan Kumar Emany has not made any transactions after 2024-03-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sravan Kumar Emany
Sravan Kumar Emany Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sravan Kumar Emany owns 1 companies in total, including Ironwood Pharmaceuticals Inc (IRWD) .
Click here to see the complete history of Sravan Kumar Emany’s form 4 insider trades.
Insider Ownership Summary of Sravan Kumar Emany
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
IRWD | Ironwood Pharmaceuticals Inc | 2024-03-04 | SVP & Chief Financial Officer |
Sravan Kumar Emany Latest Holdings Summary
Sravan Kumar Emany currently owns a total of 1 stock. Sravan Kumar Emany owns 301,733 shares of Ironwood Pharmaceuticals Inc (IRWD) as of March 4, 2024, with a value of $1 Million.
Latest Holdings of Sravan Kumar Emany
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
IRWD | Ironwood Pharmaceuticals Inc | 2024-03-04 | 301,733 | 4.78 | 1,442,284 |
Holding Weightings of Sravan Kumar Emany
Sravan Kumar Emany Form 4 Trading Tracker
According to the SEC Form 4 filings, Sravan Kumar Emany has made a total of 3 transactions in Ironwood Pharmaceuticals Inc (IRWD) over the past 5 years, including 2 buys and 1 sells. The most-recent trade in Ironwood Pharmaceuticals Inc is the acquisition of 10,684 shares on March 4, 2024, which cost Sravan Kumar Emany around $100,216.
Insider Trading History of Sravan Kumar Emany
- 1
Sravan Kumar Emany Trading Performance
GuruFocus tracks the stock performance after each of Sravan Kumar Emany's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sravan Kumar Emany is 1.67%. GuruFocus also compares Sravan Kumar Emany's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sravan Kumar Emany within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sravan Kumar Emany's insider trading performs compared to the benchmark.
Performance of Sravan Kumar Emany
Sravan Kumar Emany Ownership Network
Ownership Network List of Sravan Kumar Emany
Ownership Network Relation of Sravan Kumar Emany
Sravan Kumar Emany Owned Company Details
What does Ironwood Pharmaceuticals Inc do?
Who are the key executives at Ironwood Pharmaceuticals Inc?
Sravan Kumar Emany is the SVP & Chief Financial Officer of Ironwood Pharmaceuticals Inc. Other key executives at Ironwood Pharmaceuticals Inc include Principal Accounting Officer Ronald Silver , Chief Legal Officer Minardo John , and SVP & Chief Business Officer Andrew Davis .
Ironwood Pharmaceuticals Inc (IRWD) Insider Trades Summary
Over the past 18 months, Sravan Kumar Emany made 2 insider transaction in Ironwood Pharmaceuticals Inc (IRWD) with a net purchase of 46,756. Other recent insider transactions involving Ironwood Pharmaceuticals Inc (IRWD) include a net sale of 307,414 shares made by Thomas A Mccourt , a net sale of 81,739 shares made by Minardo John , and a net sale of 42,163 shares made by Andrew Davis .
In summary, during the past 3 months, insiders sold 0 shares of Ironwood Pharmaceuticals Inc (IRWD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 622,069 shares of Ironwood Pharmaceuticals Inc (IRWD) were sold and 53,676 shares were bought by its insiders, resulting in a net sale of 568,393 shares.
Ironwood Pharmaceuticals Inc (IRWD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ironwood Pharmaceuticals Inc Insider Transactions
Sravan Kumar Emany Mailing Address
Above is the net worth, insider trading, and ownership report for Sravan Kumar Emany. You might contact Sravan Kumar Emany via mailing address: 100 Summer St, Suite 2300, Boston Ma 02109.